CPTR Workshop 2016 Day 3: Barry Kreiswirth

Barry Kreiswerth opened this session by noting that it will have a molecular focus. Kreiswerth referenced the history of genome sequencing and some of the learnings it generated regarding M.tb. He then noted that some TB drugs – particularly, pyrazinamide – don’t seem to follow traditional patterns, leading to a need for substantial study, given its role in TB therapy.